TEM250103P45000
- 12.02
- 0.000.00%
Tempus AI Newsroom
President Capital Initiates Tempus AI at Buy With $52 Price Target
Tempus to Present at 43rd Annual J.P. Morgan Healthcare Conference
Tempus AI up After FDA Issues Draft Guidance on AI Use in Drug Decision Making
Cathie Wood's Ark Invest Books Profits On Hot AI Stock Palantir, Sells Bitcoin ETF Shares As BTC Starts 2025 On A Positive Note
DataLend: 2024 Securities Lending Revenue Down 10% YoY to $9.64 Billion
Cathie Wood's ARK Buys AMD and TEMPUS AI, Sells ARCHER AVIATION
S&P 500 Futures Drop In Premarket Trading; Sportradar Group, Cytokinetics Lead
Tempus AI Stock Plunges 28.9% in Three Months: What's Next?
Fund Managers See AI Delivering Big Gains for These 5 Stocks - Including Duolingo
Tempus AI's (TEM) AI-Powered Healthcare Revolution: What's Next?
Tempus AI(TEM.US) 10% Shareholder Sells US$7.05 Million in Common Stock
Tempus AI Inc Class A Call Volume Above Normal and Directionally Bullish
ARK Invest Shifts Focus: Adds Tempus AI, Reduces Tesla Holdings
Express News | Form 144 | Tempus AI(TEM.US) Officer Proposes to Sell 19.48 Million in Common Stocks
Tempus Signs Agreements For In-Network Provider Status With Blue Cross Blue Shield Of Illinois, Blue Shield Of California And Avalon Healthcare Solutions
Cathie Wood's ARK Investment Bought 317.6K Shares of Tempus AI Today
Why Healthcare Providers Are Increasingly Trusting Artificial Intelligence for Detection & Diagnosis
Tempus AI Announced CMS Decision That Will Allow Reimbursement Assessments Of Cardiax Dysfunctions Using Tempus ECG-AF Algorithm.
New CMS Decision Provides Medicare Coverage for the Clinical Use of the Tempus ECG-AF Device
Personalis and Tempus AI Extend Commercial Deal to Biopharma Industry